Clonal attenuation of somatic cells in aging mammals: A review of supportive evidence and its biomedical significance

Annals of the New York Academy of Sciences

Volumn 1119, Issue 1, 2007, Pages 1-8

  Martin, George M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer's disease; Atherosclerosis; Cell cell interactions; Clonal attenuation; Clonal senescence; Homeostasis; Mutator phenotype; Neoplasia; Osteoarthritis; Proliferative homeostasis; Replicative senescence; Somatic mutation; Stem cells

Indexed keywords

ATHEROSCLEROSIS; ATROPHY; ATTENUATION; AUTHOR; AUTOPSY; BIOMEDICINE; CARCINOGENESIS; CELL AGING; CELL CLONING; CELL INTERACTION; CONFERENCE PAPER; EVOLUTION; HOMEOSTASIS; HUMAN; IN VIVO STUDY; LABORATORY; LIFE; MAMMAL; MASS; NEOPLASM; NONHUMAN; OSTEOARTHRITIS; PHENOTYPE; PRIMATE; PROSTATE HYPERTROPHY; PUBLICATION; SENESCENCE; SOMATIC CELL;

MAMMALIA; PRIMATES;

EID: 36549012254     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1404.031     Document Type: Conference Paper

References (41)

1. MARTIN, G.M., E.P. BENDITT & N. ERIKSEN. 1960. Enzymic oxidation of the indole nucleus of 5-hydroxytryptamine: properties of an enzyme in human serum and of the products of oxidation. Arch. Biochem. Biophys. 90: 208-217.
2. MARTIN, G.M., E.P. BENDITT & N. ERIKSEN. 1960. Vanadium catalysis of the oxidation of catechol amines, dihydroxyphenylalanine and 5-hydroxyindoles. Nature 186: 884-885.
3. PONTECORVO, G. & E. KAFER. 1958. Genetic analysis based on mitotic recombination. Adv. Genet. 9: 71-104.
4. PONTECORVO, G. 1958. Trends in Genetic Analysis. Columbia University Press. New York.
5. HAYFLICK, L. & P.S. MOORHEAD. 1961. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25: 585-621.
6. MARTIN, G.M. 1964. Culture of replicate monolayers of fibroblasts under identical conditions. Nature 201: 1338-1340.
7. MARTIN, G.M. 1966. Clonal variation of derepressed phosphatase in chromosomally mosaic cell cultures from a child with Down's syndrome. Exp. Cell Res. 44: 341-350.
8. PAPAYANNOPOULOU, T.G. & G.M. MARTIN. 1967. Alkaline phosphatase "constitutive" clones: evidence for de-novo heterogeneity of established human skin fibroblast strains. Exp. Cell Res. 45: 72-84.
9. MARTIN, G.M., C.A. SPRAGUE, T.H. NORWOOD & W.R. PENDERGRASS. 1974. Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia. Am. J. Pathol. 74: 137-154.
10. JIH, D.M., S.L. SALCEDO & C. JAWORSKY. 2002. Benign cephalic histiocytosis: a case report and review. J. Am. Acad. Dermatol. 47: 908-913.
11. MARTIN, G.M. 1977. Cellular aging-clonal senescence. A review (Part I). Am. J. Pathol. 89: 484-511.
12. MARTIN, G.M. 1977. Cellular aging-postreplicative cells. A review (Part II). Am. J. Pathol. 89: 513-530.
13. SMITH, J.R. & R.G. WHITNEY. 1980. Intraclonal variation in proliferative potential of human diploid fibroblasts: stochastic mechanism for cellular aging. Science 207: 82-84.
14. ABSHER, M. & V.J. CRISTOFALO. 1984. Analysis of cell division by time-lapse cinematographic studies of hydrocortisone-treated embryonic lung fibroblasts. J. Cell Physiol. 119: 315-319.
15. KIRKWOOD, T.B. & R. HOLLIDAY. 1975. Commitment to senescence: a model for the finite and infinite growth of diploid and transformed human fibroblasts in culture. J. Theor. Biol. 53: 481-496.
16. EPSTEIN, C.J., G.M. MARTIN, A.L. SCHULTZ & A.G. MOTULSKY. 1966. Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Balt.) 45: 177-221.
17. MARTIN, G.M., C.A. SPRAGUE & C.J. EPSTEIN. 1970. Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab. Invest. 23: 86-92.
18. MARTIN, G.M., C.E. OGBURN & C.A. SPRAGUE. 1981. Effects of age on cell division capacity. In Aging: a Challenge to Science and Society. D. Danon, N.W. Shock & M. Marvis, Eds.: 124-135. Oxford University Press. Oxford.
19. CRISTOFALO, V.J., R.G. ALLEN, R.J. PIGNOLO, et al. 1998. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc. Natl. Acad. Sci. USA 95: 10614-10619.
20. MARTIN, G.M., C.E. OGBURN & T.N. WIGHT. 1983. Comparative rates of decline in the primary cloning efficiencies of smooth muscle cells from the aging thoracic aorta of two murine species of contrasting maximum life span potentials. Am. J. Pathol. 110: 236-245.
21. OGBURN, C.E. & G.M. MARTIN. 1985. Age-related declines in the replicative potentials of aortic cells from rhesus monkeys: evidence from primary cloning and organoid culture techniques. In Behavior and Pathology of Aging in Rhesus Monkeys: 101-106. Alan R. Liss, Inc. New York.
22. SALK, D., K. AU, H. HOEHN, et al. 1981. Evidence of clonal attenuation, clonal succession, and clonal expansion in mass cultures of aging Werner's syndrome skin fibroblasts. Cytogenet. Cell Genet. 30: 108-117.
23. DIMRI, G.P., X. LEE, G. BASILE, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92: 9363-9367.
24. HERBIG, U., M. FERREIRA, L. CONDEL, et al. 2006. Cellular senescence in aging primates. Science 311: 1257.
25. JEYAPALAN, J.C., M. FERREIRA, J.M. SEDIVY & U. HERBIG. 2007. Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 128: 36-44.
26. PASSOS, J.F., G. SARETZKI, S. AHMED, et al. 2007. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS. Biol. 5: e110.
27. RATTAN, S.I.S. 2001. "I no longer believe that cell death is programmed... ", an interview with Vincent Cristofalo. Biogerontology 2: 283-290.
28. BEN-PORATH, I. & R.A. WEINBERG. 2004. When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113: 8-13.
29. BEN-PORATH, I. & R.A. WEINBERG. 2005. The signals and pathways activating cellular senescence. Int. J. Biochem. Cell Biol. 37: 961-976.
30. MARTIN, G.M., C.A. SPRAGUE, T.H. NORWOOD, et al. 1975. Do hyperplastoid cell lines "differentiate themselves to death"? Adv. Exp. Med. Biol. 53: 67-90.
31. CAMPISI, J. 1997. Aging and cancer: the double-edged sword of replicative senescence. J. Am. Geriatr. Soc. 45: 482-488.
32. MARTIN, G.M. 1993. Clonal attenuation: causes and consequences. J. Gerontol. 48: B171-B172.
33. LORENZINI, A., M. TRESINI, S.N. AUSTAD & V.J. CRISTOFALO. 2005. Cellular replicative capacity correlates primarily with species body mass not longevity. Mech. Ageing Dev. 126: 1130-1133.
34. MARTIN, G.M. 1979. Proliferative homeostasis and its age-related aberrations. Mech. Ageing Dev. 9: 385-391.
35. WEISS, P. & J.L. KAVANAU. 1957. A model of growth and growth control in mathematical terms. J. Gen. Physiol. 41: 1-47.
36. LAGUNOFF, D. & G.M. MARTIN. 2002. Earl Philip Benditt, April 15, 1. Biogr. Mem. Natl. Acad. Sci. 81: 24-46.
37. BENDITT, E.P. & J.M. BENDITT. 1973. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA 70: 1753-1756.
38. ROSS, R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340: 115-126.
39. MARTIN, G., C. OGBURN & C. SPRAGUE. 1975. Senescence and vascular disease. In Explorations In Aging, Vol. 61. V. Cristofalo, J. Roberts & R.C. Adelman, Eds.: 163-193. Plenum. New York.
40. ZITNIK, G., L. WANG, G.M. MARTIN & Q. HU. 2007. Localizations of endogenous APP/APP-proteolytic products are consistent with microtubular transport. J. Mol. Neurosci. 31: 59-68.
41. BIELAS, J.H., K.R. LOEB, B.P. RUBIN, et al. 2006. Human cancers express a mutator phenotype. Proc. Natl. Acad. Sci. USA 103: 18238-18242.